Overview

Omegaven as Alternative Parenteral Fat Nutrition

Status:
Completed
Trial end date:
2019-01-07
Target enrollment:
Participant gender:
Summary
To provide Omegaven® as a compassionate treatment for critically ill infants with parenteral nutrition associated cholestasis
Phase:
Phase 3
Details
Lead Sponsor:
University of South Florida